LP183524-0VilazodoneActive

Description

LP183524-0 Vilazodone
Vilazodone (United States trade name Viibryd) is a serotonergic antidepressant developed for the treatment of major depressive disorder. In 2009 two phase III clinical trials with positive results were completed. Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder on January 21, 2011. Source: LOINC partner 1

Basic Part Properties

Name: Vilazodone
Type: Component
Created On: 2014-03-08
Construct for LOINC Short Name: Vilaz

Related Codes

Code System	Code	Code Text	Code Version
http://www.nlm.nih.gov/research/umls/rxnorm	1086769	Vilazodone	http://snomed.info/sct/900000000000207008/version/20170731
https://www.ebi.ac.uk/chebi	CHEBI:70707	vilazodone

LOINC FHIR^® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP183524-0

Language Variants Get Info

zh-CNChinese (China): 维拉佐酮
Synonyms: 抗抑郁药;维拉唑酮
nl-NLDutch (Netherlands): vilazodon
it-ITItalian (Italy): Vilazodone
ru-RURussian (Russian Federation): Вилазодон
es-ESSpanish (Spain): Vilazodona
tr-TRTurkish (Turkey): Vilazodon

LOINC Copyright

Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2022, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.